Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989 Nov;84(11):1353-7. PubMed PMID: 2597811.

Shaw JM, Kolesar GS, Sellers EM, Kaplan HL, Sandor P. Development of optimal treatment tactics for alcohol withdrawal. I. Assessment and effectiveness of supportive care. J Clin Psychopharmacol. 1981;1(6):382-389.

Wartenberg AA, Nirenberg TD, Liepman MR, Silvia LY, Begin AM, Monti PM. Detoxification of alcoholics: improving care by symptom-triggered sedation. Alcohol Clin Exp Res. 1990 Feb;14(1):71-5.

Kitchens JM. Does this patient have an alcohol problem? JAMA. 1994 Dec 14;272(22):1782-7.

Saitz R, Mayo-Smith MF, Roberts MS, et al. Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. JAMA 1994; 272:519.

Bird RD, Makela EH. Alcohol withdrawal: what is the benzodiazepine of choice? Ann Pharmacother 1994; 28:67.

Mayo-Smith MF. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA. 1997 Jul 9;278(2):144-51.

Schuckit M. Alcohol and alcoholism. In: Brunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. Harrison’s Principles of Internal Medicine.Vol. 2. 15th ed. New York, NY: McGraw-Hill Professional Publishing; 2001:2561–2566.

Jaeger TM, Lohr RH, Pankratz VS. Symptom-triggered therapy for alcohol withdrawal syndrome in medical inpatients. Mayo Clin Proc 2001; 76:695.

Daeppen JB, Gache P, Landry U, et al. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med 2002; 162:1117. 

Nuss MA, Elnicki DM, Dunsworth TS, Makela EH. Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome. W V Med J. 2004 Jan-Feb;100(1):21-5.

Roffman JL, Stern TA. Alcohol Withdrawal in the Setting of Elevated Blood Alcohol Levels. Primary Care Companion to The Journal of Clinical Psychiatry. 2006;8(3):170-173.

Ng K, Dahri K, Chow I, Legal M. Evaluation of an alcohol withdrawal protocol and a preprinted order set at a tertiary care hospital. Can J Hosp Pharm. 2011 Nov;64(6):436-45.

Reoux JP, Miller K. Routine hospital alcohol detoxification practice compared to symptom triggered management with an Objective Withdrawal Scale (CIWA-Ar). Am J Addict. 2000;9:135–44. PubMed PMID: 10934575.

Dr. Edward M. Sellers

CIWA-Ar for Alcohol Withdrawal

nausea

tremor

sweats

anxiety

agitation

tactile

auditory

visual_input

headache

orientation

The CIWA-Ar objectifies severity of alcohol withdrawal.

Objectifies alcohol withdrawal severity.

CIWA-Ar

Jonathan Avery, MD, is an assistant professor of psychiatry at the Weill Cornell Medical College, where he maintains a practice in general adult and addiction psychiatry. He is also an attending psychiatrist at New York-Presbyterian Hospital. Dr. Avery is a graduate of the New York University School of Medicine, and he completed residency at New York-Presbyterian Hospital/Payne Whitney Clinic. During residency, he was selected as a fellow in the Group for the Advancement of Psychiatry and won numerous awards for his clinical and academic work. Dr. Avery completed an addiction psychiatry fellowship at the New York University School of Medicine, prior to employment on the Cornell faculty. Dr. Avery now teaches addiction psychiatry and inpatient psychiatry to the Weill Cornell medical students and psychiatry residents of New York-Presbyterian Hospital. He has been published on a variety of topics in psychiatry, including clinician attitudes towards patients and how to use buprenorphine. He was also on the editorial board for the DSM-5 Clinical Cases book.

Jonathan Avery, MD

Katherine E. Taylor, MD, practices clinical psychiatry and psycho-oncology in New York City. She completed her psychiatric residency at the Payne Whitney Clinic of New York Presbyterian Hospital/Weill Cornell Medical Center and sub-specialized with a fellowship in consultation-liaison psychiatry at the New York Presbyterian Hospital/Columbia University Medical Center, focusing on the psychiatric treatment of patients with complex medical needs. Dr. Taylor currently serves on the teaching faculty at the NYU School of Medicine in the department of psychiatry, and is an attending physician at NYU Langone Perlmutter Cancer Center. In addition, she maintains a private practice and is completing further studies as a psychoanalytic candidate at the Columbia University Center for Psychoanalytic Training and Research.

Katherine E. Taylor, MD

The CIWA-Ar for Alcohol Withdrawal objectifies severity of alcohol withdrawal symptoms.

BAWS

PAWSS

EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.

Listen to the VACO co-creators break down how to use VACO\, what it does\, and what it doesn’t.

Calc Function